Rapid and sensitive analysis of 3,4-methylenedioxypyrovalerone in equine plasma using liquid chromatography-Tandem mass spectrometry

Journal of Analytical Toxicology

Volumn 36, Issue 5, 2012, Pages 327-333

  Wang, Caroline C ^a   Hartmann Fischbach, Petra ^a   Krueger, Tim R ^a   Wells, Terry L ^a   Feineman, Amy R ^a   Compton, Joanne C ^a  

^a Industrial Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYPYROVALERONE; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; 3,4-METHYLENEDIOXYPYROVALERONE; PYRROLIDINE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; DOPING; HORSE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MASS SPECTROMETER; NONHUMAN; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS; ANIMAL; ANIMAL DISEASE; BLOOD; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; VALIDATION STUDY;

ANIMALS; BENZODIOXOLES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPING IN SPORTS; HIGH-THROUGHPUT SCREENING ASSAYS; HORSES; PSYCHOTROPIC DRUGS; PYRROLIDINES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 84865857054     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bks033     Document Type: Article

References (15)

1. Ojanpera, I.A., Heikamn, P.K., Rasanen, I.J. (2011) Urine analysis of 3,4-methylenedioxypyrovalerone in opioid-dependent patients by gas chromatography-mass spectrometry. Therapeutic Drug Monitoring, 33, 257-263.
2. Boer, D.D., Bosman, I. (2004) A new trend in drug-of-abuse; The 2C-series of phenethylamine designer drugs. Pharmacy World and Science, 26, 110-113.
3. Vardakou, I., Pistos, C., Spiliopoulou, C. (2010) Spice drugs as a new trend: Mode of action, identification and legislation. Toxicology Letters, 197, 157-162.
4. Spiller, H.A., Ryan, M.L., Weston, R.G., Jansen, J. (2011) Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clinical Toxicology, 49, 499-505.
5. Lancelot, J.C., Robba, M., Bonnet, J.J., Vaugeois, J.M., Costentin, J. (1992) Synthesis and preliminary study of the acitivity of phiophene analogues of pyrovalerone on the neuronal uptake of the monoamines. European Journal of Medicinal Chemistry, 27, 297-300.
6. DEA Moves to Emergency Control Synthetic Stimulants, September 7, 2011, DEA news release, http://www.justice.gov/dea/pubs/pressrel/pr090711.html Accessed October 1st, 2011.
7. Westphal, F., Junge, T., Rosner, P., Sonnichsen, F., Schuster, F. (2009) Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: A designer drug with a-pyrrolidineophenone structure. Forensic Science International, 190, 1-8.
8. Uchiyama, N., Kikura-Hanajiri, R., Kawahara, N., Goda, Y. (2008) Analysis of designer drugs detected in the products purchased in fiscal year 2006. Yakugaku Zasshi, 128, 1499-1505 (in Japanese).
9. Strano-Rossi, S., Cadawllader, A.B., dela Torre, X., Botre, F. (2010) Toxicological determination and in vitro metobolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole timeof-flight mass spectrometry. Rapid Communications in Mass Spectrometry, 24, 2706-2714.
10. Meyer, M.R., Du, P., Schuster, F., Maurer, H.H. (2010) Studies on the metabolism of the a-pyrrolidionphenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS. Journal of Mass Spectrometry, 45, 1426-1442.
11. Jankovics, P., Varadi, A., Tolgyesi, L., Lohner, S., Nemeth-Palotas, J., Koszegi-Szalai, H. (2011) Identification and characterization of the new designer drug 4-methylethacathinone (4-MEC) and elaboration of a novel liquid chromatography-tandem mass spectrometry (LC-MS/MS) screening method for seven different methcathinone analogs. Forensic Science International, 210, 213-220.
12. Kriikku, P., Wilhelm, L., Schwarz, O., Rintatalo, J. (2011) New desinger drug of abuse: 3,4-Methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland. Forensic Science International, 210, 195-200.
13. Centers for Disease Control and Prevention (CDC). (2011) Emergency department visit after use of a drug sold as "bath salt" - Michigan, November 13, 2010-March 31, 2011. Morbidity and Mortality Weekly Report, 60, 624-627.
14. U.S. Food and Drug Administration. Guidance for Industry Bioanalytical Method Validation. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf. Accessed July 6, 2011.
15. Liu, Y., Uboh, C.E., Soma, L.R., Li, X., Guan, F., You, Y. et al. (2011) Analysis of gabapentin in equine plasma with measurement uncertainty estimation by liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology, 35, 75-84.